nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—DRD4—obesity	0.0841	0.221	CbGaD
Paliperidone—HTR1B—obesity	0.0747	0.197	CbGaD
Paliperidone—DRD1—obesity	0.0712	0.187	CbGaD
Paliperidone—HTR2C—obesity	0.0609	0.16	CbGaD
Paliperidone—DRD2—obesity	0.0502	0.132	CbGaD
Paliperidone—ADRA1B—Phendimetrazine—obesity	0.0447	0.117	CbGbCtD
Paliperidone—DRD1—Phenylpropanolamine—obesity	0.0404	0.105	CbGbCtD
Paliperidone—HTR2A—obesity	0.0388	0.102	CbGaD
Paliperidone—ADRA1A—Phendimetrazine—obesity	0.0353	0.0919	CbGbCtD
Paliperidone—ADRA2C—Methamphetamine—obesity	0.0338	0.088	CbGbCtD
Paliperidone—ADRA2B—Methamphetamine—obesity	0.0321	0.0835	CbGbCtD
Paliperidone—ADRA2A—Benzphetamine—obesity	0.0279	0.0727	CbGbCtD
Paliperidone—ADRA1A—Benzphetamine—obesity	0.0268	0.0697	CbGbCtD
Paliperidone—ADRA2A—Phenylpropanolamine—obesity	0.0266	0.0693	CbGbCtD
Paliperidone—ADRA1A—Phenylpropanolamine—obesity	0.0255	0.0665	CbGbCtD
Paliperidone—ADRA2A—Methamphetamine—obesity	0.0223	0.0581	CbGbCtD
Paliperidone—CYP3A5—Cimetidine—obesity	0.00945	0.0246	CbGbCtD
Paliperidone—CYP2D6—Phentermine—obesity	0.00928	0.0242	CbGbCtD
Paliperidone—CYP2D6—Bupropion—obesity	0.00789	0.0205	CbGbCtD
Paliperidone—CYP3A4—Sibutramine—obesity	0.00779	0.0203	CbGbCtD
Paliperidone—CYP2D6—Methamphetamine—obesity	0.00742	0.0193	CbGbCtD
Paliperidone—CYP3A4—Benzphetamine—obesity	0.0059	0.0154	CbGbCtD
Paliperidone—CYP2D6—Cimetidine—obesity	0.00579	0.0151	CbGbCtD
Paliperidone—CYP3A4—Bupropion—obesity	0.00502	0.0131	CbGbCtD
Paliperidone—CYP3A4—Orlistat—obesity	0.00409	0.0107	CbGbCtD
Paliperidone—CYP3A4—Cimetidine—obesity	0.00368	0.00959	CbGbCtD
Paliperidone—CYP3A4—Topiramate—obesity	0.00241	0.00628	CbGbCtD
Paliperidone—HTR2A—sympathetic nervous system—obesity	0.00105	0.0853	CbGeAlD
Paliperidone—HTR2A—vagus nerve—obesity	0.00101	0.0826	CbGeAlD
Paliperidone—HTR2A—autonomic nervous system—obesity	0.000704	0.0573	CbGeAlD
Paliperidone—HTR1A—hindbrain—obesity	0.000498	0.0405	CbGeAlD
Paliperidone—ADRA1A—hindbrain—obesity	0.000459	0.0374	CbGeAlD
Paliperidone—DRD2—hindbrain—obesity	0.00045	0.0366	CbGeAlD
Paliperidone—Risperidone—DRD4—obesity	0.000374	0.118	CrCbGaD
Paliperidone—Iloperidone—DRD4—obesity	0.000351	0.111	CrCbGaD
Paliperidone—Risperidone—HTR1B—obesity	0.000332	0.105	CrCbGaD
Paliperidone—Risperidone—DRD1—obesity	0.000316	0.1	CrCbGaD
Paliperidone—Iloperidone—DRD1—obesity	0.000297	0.0939	CrCbGaD
Paliperidone—HTR2A—hindbrain—obesity	0.000297	0.0241	CbGeAlD
Paliperidone—HTR1B—cardiovascular system—obesity	0.000288	0.0235	CbGeAlD
Paliperidone—HTR1D—cardiovascular system—obesity	0.000279	0.0227	CbGeAlD
Paliperidone—DRD2—respiratory system—obesity	0.000275	0.0224	CbGeAlD
Paliperidone—Risperidone—HTR2C—obesity	0.000271	0.0856	CrCbGaD
Paliperidone—CYP2D6—hindbrain—obesity	0.00027	0.022	CbGeAlD
Paliperidone—Iloperidone—HTR2C—obesity	0.000254	0.0803	CrCbGaD
Paliperidone—CYP3A5—islet of Langerhans—obesity	0.000237	0.0193	CbGeAlD
Paliperidone—HTR1A—cardiovascular system—obesity	0.000233	0.019	CbGeAlD
Paliperidone—ADRA2A—islet of Langerhans—obesity	0.000226	0.0184	CbGeAlD
Paliperidone—ADRA2C—adrenal cortex—obesity	0.000224	0.0182	CbGeAlD
Paliperidone—CYP3A5—respiratory system—obesity	0.000223	0.0182	CbGeAlD
Paliperidone—Risperidone—DRD2—obesity	0.000223	0.0705	CrCbGaD
Paliperidone—HRH1—respiratory system—obesity	0.000217	0.0177	CbGeAlD
Paliperidone—ADRA1A—cardiovascular system—obesity	0.000215	0.0175	CbGeAlD
Paliperidone—Iloperidone—DRD2—obesity	0.000209	0.0662	CrCbGaD
Paliperidone—Iloperidone—CYP2E1—obesity	0.000201	0.0637	CrCbGaD
Paliperidone—HTR1B—endocrine gland—obesity	0.000198	0.0161	CbGeAlD
Paliperidone—ADRA1A—adipose tissue—obesity	0.000189	0.0154	CbGeAlD
Paliperidone—DRD2—pituitary gland—obesity	0.000186	0.0152	CbGeAlD
Paliperidone—HTR1A—adrenal gland—obesity	0.000184	0.015	CbGeAlD
Paliperidone—HTR2A—respiratory system—obesity	0.000181	0.0147	CbGeAlD
Paliperidone—ADRA2C—pituitary gland—obesity	0.000181	0.0147	CbGeAlD
Paliperidone—ADRA2C—adipose tissue—obesity	0.00018	0.0147	CbGeAlD
Paliperidone—Risperidone—HTR2A—obesity	0.000172	0.0545	CrCbGaD
Paliperidone—ADRA1A—adrenal gland—obesity	0.00017	0.0138	CbGeAlD
Paliperidone—ADRA2C—adrenal gland—obesity	0.000162	0.0132	CbGeAlD
Paliperidone—Iloperidone—HTR2A—obesity	0.000162	0.0511	CrCbGaD
Paliperidone—HTR1A—endocrine gland—obesity	0.00016	0.013	CbGeAlD
Paliperidone—CYP3A5—adipose tissue—obesity	0.000151	0.0123	CbGeAlD
Paliperidone—ADRA1A—endocrine gland—obesity	0.000147	0.012	CbGeAlD
Paliperidone—HRH1—adipose tissue—obesity	0.000146	0.0119	CbGeAlD
Paliperidone—ADRA2A—pituitary gland—obesity	0.000144	0.0118	CbGeAlD
Paliperidone—DRD2—endocrine gland—obesity	0.000144	0.0117	CbGeAlD
Paliperidone—ADRA2A—adipose tissue—obesity	0.000144	0.0117	CbGeAlD
Paliperidone—CYP3A5—digestive system—obesity	0.000142	0.0116	CbGeAlD
Paliperidone—HTR2A—cardiovascular system—obesity	0.000139	0.0113	CbGeAlD
Paliperidone—HRH1—digestive system—obesity	0.000138	0.0112	CbGeAlD
Paliperidone—ADRA1A—liver—obesity	0.000133	0.0108	CbGeAlD
Paliperidone—HRH1—adrenal gland—obesity	0.000131	0.0107	CbGeAlD
Paliperidone—ADRA2A—adrenal gland—obesity	0.000129	0.0105	CbGeAlD
Paliperidone—ADRA2C—liver—obesity	0.000126	0.0103	CbGeAlD
Paliperidone—HTR2A—pituitary gland—obesity	0.000123	0.01	CbGeAlD
Paliperidone—CYP3A5—endocrine gland—obesity	0.000117	0.00956	CbGeAlD
Paliperidone—HTR2A—digestive system—obesity	0.000115	0.00938	CbGeAlD
Paliperidone—HRH1—endocrine gland—obesity	0.000114	0.00928	CbGeAlD
Paliperidone—ADRA2A—endocrine gland—obesity	0.000112	0.00911	CbGeAlD
Paliperidone—HTR2A—adrenal gland—obesity	0.00011	0.00893	CbGeAlD
Paliperidone—CYP3A4—digestive system—obesity	0.000107	0.00868	CbGeAlD
Paliperidone—CYP3A5—liver—obesity	0.000106	0.00862	CbGeAlD
Paliperidone—CYP2D6—digestive system—obesity	0.000105	0.00854	CbGeAlD
Paliperidone—HTR2A—endocrine gland—obesity	9.51e-05	0.00775	CbGeAlD
Paliperidone—CYP3A4—endocrine gland—obesity	8.81e-05	0.00717	CbGeAlD
Paliperidone—CYP2D6—endocrine gland—obesity	8.67e-05	0.00706	CbGeAlD
Paliperidone—HTR2A—liver—obesity	8.58e-05	0.00699	CbGeAlD
Paliperidone—CYP3A4—liver—obesity	7.94e-05	0.00647	CbGeAlD
Paliperidone—CYP2D6—liver—obesity	7.82e-05	0.00636	CbGeAlD
Paliperidone—Cough—Sibutramine—obesity	7.19e-05	0.000591	CcSEcCtD
Paliperidone—Malnutrition—Bupropion—obesity	7.18e-05	0.00059	CcSEcCtD
Paliperidone—Discomfort—Orlistat—obesity	7.16e-05	0.000589	CcSEcCtD
Paliperidone—Convulsion—Sibutramine—obesity	7.14e-05	0.000587	CcSEcCtD
Paliperidone—Hypertension—Sibutramine—obesity	7.11e-05	0.000585	CcSEcCtD
Paliperidone—Dry mouth—Orlistat—obesity	7.09e-05	0.000583	CcSEcCtD
Paliperidone—Flatulence—Bupropion—obesity	7.08e-05	0.000582	CcSEcCtD
Paliperidone—Tension—Bupropion—obesity	7.05e-05	0.000579	CcSEcCtD
Paliperidone—Dysgeusia—Bupropion—obesity	7.03e-05	0.000578	CcSEcCtD
Paliperidone—Arthralgia—Sibutramine—obesity	7.01e-05	0.000576	CcSEcCtD
Paliperidone—Chest pain—Sibutramine—obesity	7.01e-05	0.000576	CcSEcCtD
Paliperidone—Myalgia—Sibutramine—obesity	7.01e-05	0.000576	CcSEcCtD
Paliperidone—Anxiety—Sibutramine—obesity	6.99e-05	0.000574	CcSEcCtD
Paliperidone—Nervousness—Bupropion—obesity	6.97e-05	0.000573	CcSEcCtD
Paliperidone—Anaphylactic shock—Orlistat—obesity	6.95e-05	0.000571	CcSEcCtD
Paliperidone—Oedema—Orlistat—obesity	6.95e-05	0.000571	CcSEcCtD
Paliperidone—Back pain—Bupropion—obesity	6.95e-05	0.000571	CcSEcCtD
Paliperidone—Orthostatic hypotension—Topiramate—obesity	6.94e-05	0.00057	CcSEcCtD
Paliperidone—Abdominal pain upper—Topiramate—obesity	6.94e-05	0.00057	CcSEcCtD
Paliperidone—Discomfort—Sibutramine—obesity	6.93e-05	0.00057	CcSEcCtD
Paliperidone—Muscle spasms—Bupropion—obesity	6.9e-05	0.000568	CcSEcCtD
Paliperidone—Infection—Orlistat—obesity	6.9e-05	0.000567	CcSEcCtD
Paliperidone—Breast disorder—Topiramate—obesity	6.86e-05	0.000564	CcSEcCtD
Paliperidone—Dry mouth—Sibutramine—obesity	6.86e-05	0.000564	CcSEcCtD
Paliperidone—Aspartate aminotransferase increased—Topiramate—obesity	6.84e-05	0.000562	CcSEcCtD
Paliperidone—Nervous system disorder—Orlistat—obesity	6.81e-05	0.00056	CcSEcCtD
Paliperidone—Nasopharyngitis—Topiramate—obesity	6.79e-05	0.000558	CcSEcCtD
Paliperidone—Confusional state—Sibutramine—obesity	6.78e-05	0.000557	CcSEcCtD
Paliperidone—Vision blurred—Bupropion—obesity	6.77e-05	0.000556	CcSEcCtD
Paliperidone—Skin disorder—Orlistat—obesity	6.75e-05	0.000555	CcSEcCtD
Paliperidone—Tremor—Bupropion—obesity	6.73e-05	0.000553	CcSEcCtD
Paliperidone—Anaphylactic shock—Sibutramine—obesity	6.72e-05	0.000553	CcSEcCtD
Paliperidone—Oedema—Sibutramine—obesity	6.72e-05	0.000553	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Topiramate—obesity	6.7e-05	0.000551	CcSEcCtD
Paliperidone—Muscular weakness—Topiramate—obesity	6.7e-05	0.000551	CcSEcCtD
Paliperidone—Infection—Sibutramine—obesity	6.68e-05	0.000549	CcSEcCtD
Paliperidone—Ill-defined disorder—Bupropion—obesity	6.66e-05	0.000548	CcSEcCtD
Paliperidone—Anaemia—Bupropion—obesity	6.64e-05	0.000546	CcSEcCtD
Paliperidone—Shock—Sibutramine—obesity	6.61e-05	0.000544	CcSEcCtD
Paliperidone—Agitation—Bupropion—obesity	6.6e-05	0.000542	CcSEcCtD
Paliperidone—Thrombocytopenia—Sibutramine—obesity	6.58e-05	0.000541	CcSEcCtD
Paliperidone—Dysphagia—Topiramate—obesity	6.57e-05	0.00054	CcSEcCtD
Paliperidone—Angioedema—Bupropion—obesity	6.56e-05	0.000539	CcSEcCtD
Paliperidone—Tachycardia—Sibutramine—obesity	6.56e-05	0.000539	CcSEcCtD
Paliperidone—Skin disorder—Sibutramine—obesity	6.53e-05	0.000537	CcSEcCtD
Paliperidone—Malaise—Bupropion—obesity	6.48e-05	0.000532	CcSEcCtD
Paliperidone—Vertigo—Bupropion—obesity	6.45e-05	0.00053	CcSEcCtD
Paliperidone—Syncope—Bupropion—obesity	6.44e-05	0.000529	CcSEcCtD
Paliperidone—Pancreatitis—Topiramate—obesity	6.44e-05	0.000529	CcSEcCtD
Paliperidone—Leukopenia—Bupropion—obesity	6.43e-05	0.000528	CcSEcCtD
Paliperidone—Anorexia—Sibutramine—obesity	6.41e-05	0.000527	CcSEcCtD
Paliperidone—Palpitations—Bupropion—obesity	6.35e-05	0.000522	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Orlistat—obesity	6.33e-05	0.00052	CcSEcCtD
Paliperidone—Bronchitis—Topiramate—obesity	6.31e-05	0.000519	CcSEcCtD
Paliperidone—Loss of consciousness—Bupropion—obesity	6.31e-05	0.000519	CcSEcCtD
Paliperidone—Abdominal discomfort—Topiramate—obesity	6.29e-05	0.000517	CcSEcCtD
Paliperidone—Insomnia—Orlistat—obesity	6.28e-05	0.000516	CcSEcCtD
Paliperidone—Hypotension—Sibutramine—obesity	6.28e-05	0.000516	CcSEcCtD
Paliperidone—Cough—Bupropion—obesity	6.27e-05	0.000515	CcSEcCtD
Paliperidone—Paraesthesia—Orlistat—obesity	6.24e-05	0.000513	CcSEcCtD
Paliperidone—Convulsion—Bupropion—obesity	6.22e-05	0.000511	CcSEcCtD
Paliperidone—Hypertension—Bupropion—obesity	6.2e-05	0.00051	CcSEcCtD
Paliperidone—Dysuria—Topiramate—obesity	6.14e-05	0.000505	CcSEcCtD
Paliperidone—Neutropenia—Topiramate—obesity	6.14e-05	0.000505	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Sibutramine—obesity	6.12e-05	0.000503	CcSEcCtD
Paliperidone—Dyspepsia—Orlistat—obesity	6.11e-05	0.000503	CcSEcCtD
Paliperidone—Chest pain—Bupropion—obesity	6.11e-05	0.000503	CcSEcCtD
Paliperidone—Arthralgia—Bupropion—obesity	6.11e-05	0.000503	CcSEcCtD
Paliperidone—Myalgia—Bupropion—obesity	6.11e-05	0.000503	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Topiramate—obesity	6.1e-05	0.000502	CcSEcCtD
Paliperidone—Anxiety—Bupropion—obesity	6.09e-05	0.000501	CcSEcCtD
Paliperidone—Insomnia—Sibutramine—obesity	6.08e-05	0.0005	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	6.07e-05	0.000499	CcSEcCtD
Paliperidone—Pollakiuria—Topiramate—obesity	6.07e-05	0.000499	CcSEcCtD
Paliperidone—Erectile dysfunction—Topiramate—obesity	6.05e-05	0.000497	CcSEcCtD
Paliperidone—Discomfort—Bupropion—obesity	6.04e-05	0.000497	CcSEcCtD
Paliperidone—Decreased appetite—Orlistat—obesity	6.04e-05	0.000496	CcSEcCtD
Paliperidone—Paraesthesia—Sibutramine—obesity	6.04e-05	0.000496	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Orlistat—obesity	6e-05	0.000493	CcSEcCtD
Paliperidone—Dyspnoea—Sibutramine—obesity	5.99e-05	0.000493	CcSEcCtD
Paliperidone—Fatigue—Orlistat—obesity	5.99e-05	0.000492	CcSEcCtD
Paliperidone—Dry mouth—Bupropion—obesity	5.98e-05	0.000491	CcSEcCtD
Paliperidone—Somnolence—Sibutramine—obesity	5.98e-05	0.000491	CcSEcCtD
Paliperidone—Weight increased—Topiramate—obesity	5.98e-05	0.000491	CcSEcCtD
Paliperidone—Weight decreased—Topiramate—obesity	5.94e-05	0.000488	CcSEcCtD
Paliperidone—Pain—Orlistat—obesity	5.94e-05	0.000488	CcSEcCtD
Paliperidone—Hyperglycaemia—Topiramate—obesity	5.92e-05	0.000487	CcSEcCtD
Paliperidone—Dyspepsia—Sibutramine—obesity	5.92e-05	0.000486	CcSEcCtD
Paliperidone—Confusional state—Bupropion—obesity	5.91e-05	0.000486	CcSEcCtD
Paliperidone—Pneumonia—Topiramate—obesity	5.89e-05	0.000484	CcSEcCtD
Paliperidone—Oedema—Bupropion—obesity	5.86e-05	0.000482	CcSEcCtD
Paliperidone—Anaphylactic shock—Bupropion—obesity	5.86e-05	0.000482	CcSEcCtD
Paliperidone—Infestation NOS—Topiramate—obesity	5.85e-05	0.000481	CcSEcCtD
Paliperidone—Infestation—Topiramate—obesity	5.85e-05	0.000481	CcSEcCtD
Paliperidone—Decreased appetite—Sibutramine—obesity	5.84e-05	0.00048	CcSEcCtD
Paliperidone—Depression—Topiramate—obesity	5.84e-05	0.00048	CcSEcCtD
Paliperidone—Infection—Bupropion—obesity	5.82e-05	0.000479	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Sibutramine—obesity	5.8e-05	0.000477	CcSEcCtD
Paliperidone—Shock—Bupropion—obesity	5.77e-05	0.000474	CcSEcCtD
Paliperidone—Constipation—Sibutramine—obesity	5.75e-05	0.000473	CcSEcCtD
Paliperidone—Pain—Sibutramine—obesity	5.75e-05	0.000473	CcSEcCtD
Paliperidone—Nervous system disorder—Bupropion—obesity	5.75e-05	0.000472	CcSEcCtD
Paliperidone—Thrombocytopenia—Bupropion—obesity	5.74e-05	0.000472	CcSEcCtD
Paliperidone—Feeling abnormal—Orlistat—obesity	5.72e-05	0.000471	CcSEcCtD
Paliperidone—Tachycardia—Bupropion—obesity	5.72e-05	0.00047	CcSEcCtD
Paliperidone—Skin disorder—Bupropion—obesity	5.69e-05	0.000468	CcSEcCtD
Paliperidone—Conjunctivitis—Topiramate—obesity	5.69e-05	0.000468	CcSEcCtD
Paliperidone—Urinary tract infection—Topiramate—obesity	5.69e-05	0.000468	CcSEcCtD
Paliperidone—Gastrointestinal pain—Orlistat—obesity	5.68e-05	0.000467	CcSEcCtD
Paliperidone—Anorexia—Bupropion—obesity	5.59e-05	0.000459	CcSEcCtD
Paliperidone—Feeling abnormal—Sibutramine—obesity	5.54e-05	0.000455	CcSEcCtD
Paliperidone—Epistaxis—Topiramate—obesity	5.52e-05	0.000454	CcSEcCtD
Paliperidone—Urticaria—Orlistat—obesity	5.52e-05	0.000454	CcSEcCtD
Paliperidone—Gastrointestinal pain—Sibutramine—obesity	5.5e-05	0.000452	CcSEcCtD
Paliperidone—Sinusitis—Topiramate—obesity	5.49e-05	0.000451	CcSEcCtD
Paliperidone—Abdominal pain—Orlistat—obesity	5.49e-05	0.000451	CcSEcCtD
Paliperidone—Body temperature increased—Orlistat—obesity	5.49e-05	0.000451	CcSEcCtD
Paliperidone—Hypotension—Bupropion—obesity	5.48e-05	0.00045	CcSEcCtD
Paliperidone—Agranulocytosis—Topiramate—obesity	5.46e-05	0.000449	CcSEcCtD
Paliperidone—Bradycardia—Topiramate—obesity	5.35e-05	0.00044	CcSEcCtD
Paliperidone—Urticaria—Sibutramine—obesity	5.34e-05	0.000439	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Bupropion—obesity	5.34e-05	0.000439	CcSEcCtD
Paliperidone—Abdominal pain—Sibutramine—obesity	5.31e-05	0.000437	CcSEcCtD
Paliperidone—Body temperature increased—Sibutramine—obesity	5.31e-05	0.000437	CcSEcCtD
Paliperidone—Insomnia—Bupropion—obesity	5.3e-05	0.000436	CcSEcCtD
Paliperidone—Rhinitis—Topiramate—obesity	5.27e-05	0.000433	CcSEcCtD
Paliperidone—Paraesthesia—Bupropion—obesity	5.26e-05	0.000433	CcSEcCtD
Paliperidone—Hypoaesthesia—Topiramate—obesity	5.23e-05	0.00043	CcSEcCtD
Paliperidone—Dyspnoea—Bupropion—obesity	5.22e-05	0.00043	CcSEcCtD
Paliperidone—Somnolence—Bupropion—obesity	5.21e-05	0.000428	CcSEcCtD
Paliperidone—Urinary tract disorder—Topiramate—obesity	5.19e-05	0.000427	CcSEcCtD
Paliperidone—Oedema peripheral—Topiramate—obesity	5.18e-05	0.000426	CcSEcCtD
Paliperidone—Connective tissue disorder—Topiramate—obesity	5.16e-05	0.000425	CcSEcCtD
Paliperidone—Dyspepsia—Bupropion—obesity	5.16e-05	0.000424	CcSEcCtD
Paliperidone—Urethral disorder—Topiramate—obesity	5.15e-05	0.000423	CcSEcCtD
Paliperidone—Hypersensitivity—Orlistat—obesity	5.12e-05	0.000421	CcSEcCtD
Paliperidone—Decreased appetite—Bupropion—obesity	5.09e-05	0.000419	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Bupropion—obesity	5.06e-05	0.000416	CcSEcCtD
Paliperidone—Fatigue—Bupropion—obesity	5.05e-05	0.000415	CcSEcCtD
Paliperidone—Constipation—Bupropion—obesity	5.01e-05	0.000412	CcSEcCtD
Paliperidone—Pain—Bupropion—obesity	5.01e-05	0.000412	CcSEcCtD
Paliperidone—Asthenia—Orlistat—obesity	4.98e-05	0.00041	CcSEcCtD
Paliperidone—Hypersensitivity—Sibutramine—obesity	4.95e-05	0.000407	CcSEcCtD
Paliperidone—Pruritus—Orlistat—obesity	4.91e-05	0.000404	CcSEcCtD
Paliperidone—Eye disorder—Topiramate—obesity	4.91e-05	0.000404	CcSEcCtD
Paliperidone—Tinnitus—Topiramate—obesity	4.9e-05	0.000403	CcSEcCtD
Paliperidone—Flushing—Topiramate—obesity	4.88e-05	0.000401	CcSEcCtD
Paliperidone—Cardiac disorder—Topiramate—obesity	4.88e-05	0.000401	CcSEcCtD
Paliperidone—Feeling abnormal—Bupropion—obesity	4.83e-05	0.000397	CcSEcCtD
Paliperidone—Asthenia—Sibutramine—obesity	4.82e-05	0.000396	CcSEcCtD
Paliperidone—Gastrointestinal pain—Bupropion—obesity	4.79e-05	0.000394	CcSEcCtD
Paliperidone—Angiopathy—Topiramate—obesity	4.77e-05	0.000392	CcSEcCtD
Paliperidone—Pruritus—Sibutramine—obesity	4.76e-05	0.000391	CcSEcCtD
Paliperidone—Diarrhoea—Orlistat—obesity	4.75e-05	0.000391	CcSEcCtD
Paliperidone—Immune system disorder—Topiramate—obesity	4.75e-05	0.00039	CcSEcCtD
Paliperidone—Mediastinal disorder—Topiramate—obesity	4.74e-05	0.000389	CcSEcCtD
Paliperidone—Chills—Topiramate—obesity	4.72e-05	0.000388	CcSEcCtD
Paliperidone—Urticaria—Bupropion—obesity	4.66e-05	0.000383	CcSEcCtD
Paliperidone—Alopecia—Topiramate—obesity	4.64e-05	0.000382	CcSEcCtD
Paliperidone—Body temperature increased—Bupropion—obesity	4.63e-05	0.000381	CcSEcCtD
Paliperidone—Abdominal pain—Bupropion—obesity	4.63e-05	0.000381	CcSEcCtD
Paliperidone—Mental disorder—Topiramate—obesity	4.6e-05	0.000378	CcSEcCtD
Paliperidone—Diarrhoea—Sibutramine—obesity	4.6e-05	0.000378	CcSEcCtD
Paliperidone—Dizziness—Orlistat—obesity	4.59e-05	0.000378	CcSEcCtD
Paliperidone—Malnutrition—Topiramate—obesity	4.57e-05	0.000376	CcSEcCtD
Paliperidone—Erythema—Topiramate—obesity	4.57e-05	0.000376	CcSEcCtD
Paliperidone—Flatulence—Topiramate—obesity	4.51e-05	0.000371	CcSEcCtD
Paliperidone—Tension—Topiramate—obesity	4.49e-05	0.000369	CcSEcCtD
Paliperidone—Dysgeusia—Topiramate—obesity	4.48e-05	0.000368	CcSEcCtD
Paliperidone—Dizziness—Sibutramine—obesity	4.45e-05	0.000365	CcSEcCtD
Paliperidone—Nervousness—Topiramate—obesity	4.44e-05	0.000365	CcSEcCtD
Paliperidone—Back pain—Topiramate—obesity	4.43e-05	0.000364	CcSEcCtD
Paliperidone—Vomiting—Orlistat—obesity	4.42e-05	0.000363	CcSEcCtD
Paliperidone—Muscle spasms—Topiramate—obesity	4.4e-05	0.000362	CcSEcCtD
Paliperidone—Rash—Orlistat—obesity	4.38e-05	0.00036	CcSEcCtD
Paliperidone—Dermatitis—Orlistat—obesity	4.38e-05	0.00036	CcSEcCtD
Paliperidone—Headache—Orlistat—obesity	4.35e-05	0.000358	CcSEcCtD
Paliperidone—Hypersensitivity—Bupropion—obesity	4.32e-05	0.000355	CcSEcCtD
Paliperidone—Vision blurred—Topiramate—obesity	4.31e-05	0.000354	CcSEcCtD
Paliperidone—Tremor—Topiramate—obesity	4.29e-05	0.000352	CcSEcCtD
Paliperidone—Vomiting—Sibutramine—obesity	4.27e-05	0.000351	CcSEcCtD
Paliperidone—Ill-defined disorder—Topiramate—obesity	4.24e-05	0.000349	CcSEcCtD
Paliperidone—Rash—Sibutramine—obesity	4.24e-05	0.000348	CcSEcCtD
Paliperidone—Dermatitis—Sibutramine—obesity	4.23e-05	0.000348	CcSEcCtD
Paliperidone—Anaemia—Topiramate—obesity	4.23e-05	0.000348	CcSEcCtD
Paliperidone—Headache—Sibutramine—obesity	4.21e-05	0.000346	CcSEcCtD
Paliperidone—Asthenia—Bupropion—obesity	4.2e-05	0.000346	CcSEcCtD
Paliperidone—Agitation—Topiramate—obesity	4.2e-05	0.000346	CcSEcCtD
Paliperidone—Pruritus—Bupropion—obesity	4.15e-05	0.000341	CcSEcCtD
Paliperidone—Nausea—Orlistat—obesity	4.13e-05	0.000339	CcSEcCtD
Paliperidone—Malaise—Topiramate—obesity	4.13e-05	0.000339	CcSEcCtD
Paliperidone—Vertigo—Topiramate—obesity	4.11e-05	0.000338	CcSEcCtD
Paliperidone—Syncope—Topiramate—obesity	4.1e-05	0.000337	CcSEcCtD
Paliperidone—Leukopenia—Topiramate—obesity	4.1e-05	0.000337	CcSEcCtD
Paliperidone—Palpitations—Topiramate—obesity	4.04e-05	0.000332	CcSEcCtD
Paliperidone—Loss of consciousness—Topiramate—obesity	4.02e-05	0.000331	CcSEcCtD
Paliperidone—Diarrhoea—Bupropion—obesity	4.01e-05	0.00033	CcSEcCtD
Paliperidone—Nausea—Sibutramine—obesity	3.99e-05	0.000328	CcSEcCtD
Paliperidone—Cough—Topiramate—obesity	3.99e-05	0.000328	CcSEcCtD
Paliperidone—Convulsion—Topiramate—obesity	3.96e-05	0.000326	CcSEcCtD
Paliperidone—Hypertension—Topiramate—obesity	3.95e-05	0.000325	CcSEcCtD
Paliperidone—Arthralgia—Topiramate—obesity	3.89e-05	0.00032	CcSEcCtD
Paliperidone—Chest pain—Topiramate—obesity	3.89e-05	0.00032	CcSEcCtD
Paliperidone—Myalgia—Topiramate—obesity	3.89e-05	0.00032	CcSEcCtD
Paliperidone—Anxiety—Topiramate—obesity	3.88e-05	0.000319	CcSEcCtD
Paliperidone—Dizziness—Bupropion—obesity	3.88e-05	0.000319	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	3.87e-05	0.000318	CcSEcCtD
Paliperidone—Discomfort—Topiramate—obesity	3.85e-05	0.000316	CcSEcCtD
Paliperidone—Dry mouth—Topiramate—obesity	3.81e-05	0.000313	CcSEcCtD
Paliperidone—Confusional state—Topiramate—obesity	3.76e-05	0.000309	CcSEcCtD
Paliperidone—Oedema—Topiramate—obesity	3.73e-05	0.000307	CcSEcCtD
Paliperidone—Vomiting—Bupropion—obesity	3.73e-05	0.000306	CcSEcCtD
Paliperidone—Infection—Topiramate—obesity	3.71e-05	0.000305	CcSEcCtD
Paliperidone—Rash—Bupropion—obesity	3.7e-05	0.000304	CcSEcCtD
Paliperidone—Dermatitis—Bupropion—obesity	3.69e-05	0.000303	CcSEcCtD
Paliperidone—Shock—Topiramate—obesity	3.67e-05	0.000302	CcSEcCtD
Paliperidone—Headache—Bupropion—obesity	3.67e-05	0.000302	CcSEcCtD
Paliperidone—Nervous system disorder—Topiramate—obesity	3.66e-05	0.000301	CcSEcCtD
Paliperidone—Thrombocytopenia—Topiramate—obesity	3.66e-05	0.000301	CcSEcCtD
Paliperidone—Tachycardia—Topiramate—obesity	3.64e-05	0.0003	CcSEcCtD
Paliperidone—Skin disorder—Topiramate—obesity	3.63e-05	0.000298	CcSEcCtD
Paliperidone—Anorexia—Topiramate—obesity	3.56e-05	0.000293	CcSEcCtD
Paliperidone—Hypotension—Topiramate—obesity	3.49e-05	0.000287	CcSEcCtD
Paliperidone—Nausea—Bupropion—obesity	3.48e-05	0.000286	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Topiramate—obesity	3.4e-05	0.00028	CcSEcCtD
Paliperidone—Insomnia—Topiramate—obesity	3.38e-05	0.000278	CcSEcCtD
Paliperidone—Paraesthesia—Topiramate—obesity	3.35e-05	0.000276	CcSEcCtD
Paliperidone—Dyspnoea—Topiramate—obesity	3.33e-05	0.000274	CcSEcCtD
Paliperidone—Somnolence—Topiramate—obesity	3.32e-05	0.000273	CcSEcCtD
Paliperidone—Dyspepsia—Topiramate—obesity	3.29e-05	0.00027	CcSEcCtD
Paliperidone—Decreased appetite—Topiramate—obesity	3.25e-05	0.000267	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Topiramate—obesity	3.22e-05	0.000265	CcSEcCtD
Paliperidone—Fatigue—Topiramate—obesity	3.22e-05	0.000265	CcSEcCtD
Paliperidone—Constipation—Topiramate—obesity	3.19e-05	0.000262	CcSEcCtD
Paliperidone—Pain—Topiramate—obesity	3.19e-05	0.000262	CcSEcCtD
Paliperidone—Feeling abnormal—Topiramate—obesity	3.08e-05	0.000253	CcSEcCtD
Paliperidone—Gastrointestinal pain—Topiramate—obesity	3.05e-05	0.000251	CcSEcCtD
Paliperidone—Urticaria—Topiramate—obesity	2.97e-05	0.000244	CcSEcCtD
Paliperidone—Abdominal pain—Topiramate—obesity	2.95e-05	0.000243	CcSEcCtD
Paliperidone—Body temperature increased—Topiramate—obesity	2.95e-05	0.000243	CcSEcCtD
Paliperidone—Hypersensitivity—Topiramate—obesity	2.75e-05	0.000226	CcSEcCtD
Paliperidone—Asthenia—Topiramate—obesity	2.68e-05	0.00022	CcSEcCtD
Paliperidone—Pruritus—Topiramate—obesity	2.64e-05	0.000217	CcSEcCtD
Paliperidone—Diarrhoea—Topiramate—obesity	2.55e-05	0.00021	CcSEcCtD
Paliperidone—Dizziness—Topiramate—obesity	2.47e-05	0.000203	CcSEcCtD
Paliperidone—Vomiting—Topiramate—obesity	2.37e-05	0.000195	CcSEcCtD
Paliperidone—Rash—Topiramate—obesity	2.35e-05	0.000194	CcSEcCtD
Paliperidone—Dermatitis—Topiramate—obesity	2.35e-05	0.000193	CcSEcCtD
Paliperidone—Headache—Topiramate—obesity	2.34e-05	0.000192	CcSEcCtD
Paliperidone—Nausea—Topiramate—obesity	2.22e-05	0.000182	CcSEcCtD
Paliperidone—CYP3A4—Metabolism—FASN—obesity	1.02e-06	1.03e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MYC—obesity	1.02e-06	1.03e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—BCHE—obesity	1.02e-06	1.03e-05	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—AKT1—obesity	1.02e-06	1.03e-05	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	1.02e-06	1.03e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—RHOA—obesity	1.02e-06	1.03e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—obesity	1.01e-06	1.03e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—SERPINE1—obesity	1.01e-06	1.02e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL2—obesity	1.01e-06	1.02e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TYK2—obesity	1.01e-06	1.02e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MTOR—obesity	1.01e-06	1.02e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PIK3CB—obesity	1.01e-06	1.02e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TYK2—obesity	1.01e-06	1.02e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—MTHFR—obesity	1.01e-06	1.02e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PIK3R1—obesity	1.01e-06	1.02e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NOS3—obesity	1.01e-06	1.02e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—obesity	1e-06	1.01e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—RHOA—obesity	9.99e-07	1.01e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—RHOA—obesity	9.97e-07	1.01e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MYC—obesity	9.96e-07	1.01e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—obesity	9.94e-07	1e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PIK3CB—obesity	9.93e-07	1e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IGF1—obesity	9.92e-07	1e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKT2—obesity	9.92e-07	1e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PIK3R1—obesity	9.89e-07	9.99e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NOS3—obesity	9.89e-07	9.99e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PIK3R1—obesity	9.87e-07	9.97e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NOS3—obesity	9.87e-07	9.97e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TYK2—obesity	9.87e-07	9.96e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARA—obesity	9.86e-07	9.96e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PIK3R1—obesity	9.86e-07	9.96e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—NOS3—obesity	9.86e-07	9.96e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—obesity	9.84e-07	9.94e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYP2E1—obesity	9.81e-07	9.91e-06	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—AKT1—obesity	9.81e-07	9.91e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MYC—obesity	9.8e-07	9.9e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—RHOA—obesity	9.78e-07	9.88e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—obesity	9.78e-07	9.88e-06	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—AKT1—obesity	9.76e-07	9.86e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NQO1—obesity	9.7e-07	9.8e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PIK3R1—obesity	9.68e-07	9.78e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NOS3—obesity	9.68e-07	9.78e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—obesity	9.66e-07	9.75e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—obesity	9.61e-07	9.7e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—PIK3CA—obesity	9.57e-07	9.67e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AGT—obesity	9.55e-07	9.65e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PIK3CD—obesity	9.53e-07	9.62e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MMP9—obesity	9.51e-07	9.61e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—STAT3—obesity	9.5e-07	9.59e-06	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—AKT1—obesity	9.49e-07	9.59e-06	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	9.44e-07	9.53e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—SERPINE1—obesity	9.42e-07	9.52e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—PIK3CA—obesity	9.42e-07	9.51e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—PIK3CA—obesity	9.4e-07	9.49e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—STAT3—obesity	9.37e-07	9.46e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOE—obesity	9.36e-07	9.45e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—obesity	9.34e-07	9.44e-06	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—AKT1—obesity	9.34e-07	9.44e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GCG—obesity	9.3e-07	9.4e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SLC2A4—obesity	9.3e-07	9.4e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MTOR—obesity	9.28e-07	9.37e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PIK3CB—obesity	9.28e-07	9.37e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CAV1—obesity	9.27e-07	9.37e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MAPK8—obesity	9.25e-07	9.35e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOA1—obesity	9.25e-07	9.34e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—AKT1—obesity	9.23e-07	9.32e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—PIK3CA—obesity	9.22e-07	9.32e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—obesity	9.2e-07	9.29e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MMP9—obesity	9.18e-07	9.28e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYCS—obesity	9.18e-07	9.27e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TYK2—obesity	9.17e-07	9.26e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MMP9—obesity	9.14e-07	9.23e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PIK3CB—obesity	9.13e-07	9.22e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MTOR—obesity	9.13e-07	9.22e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PIK3CB—obesity	9.11e-07	9.2e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MTOR—obesity	9.11e-07	9.2e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PIK3CB—obesity	9.1e-07	9.19e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—RHOA—obesity	9.09e-07	9.18e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—obesity	9.02e-07	9.11e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GOT1—obesity	9.01e-07	9.1e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GGT1—obesity	9.01e-07	9.1e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PIK3R1—obesity	9e-07	9.09e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOS3—obesity	9e-07	9.09e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MTOR—obesity	8.94e-07	9.03e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PIK3CB—obesity	8.94e-07	9.03e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MAPK8—obesity	8.93e-07	9.02e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—AKT1—obesity	8.91e-07	9e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MMP9—obesity	8.89e-07	8.98e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MAPK8—obesity	8.89e-07	8.98e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NCOA1—obesity	8.87e-07	8.96e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—AKT1—obesity	8.86e-07	8.95e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MYC—obesity	8.82e-07	8.91e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—obesity	8.8e-07	8.89e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MMP9—obesity	8.75e-07	8.83e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYP19A1—obesity	8.75e-07	8.83e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—STK11—obesity	8.75e-07	8.83e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MYC—obesity	8.71e-07	8.79e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—obesity	8.69e-07	8.77e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MAPK8—obesity	8.64e-07	8.73e-06	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—PIK3CA—obesity	8.64e-07	8.72e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—AKT1—obesity	8.62e-07	8.71e-06	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—AKT1—obesity	8.61e-07	8.7e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—PIK3CA—obesity	8.57e-07	8.66e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MAPK8—obesity	8.51e-07	8.59e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—AKT1—obesity	8.48e-07	8.57e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—obesity	8.48e-07	8.56e-06	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—AKT1—obesity	8.47e-07	8.56e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—STAT3—obesity	8.46e-07	8.54e-06	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—AKT1—obesity	8.46e-07	8.54e-06	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—PIK3CA—obesity	8.46e-07	8.54e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3CG—obesity	8.45e-07	8.53e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—obesity	8.34e-07	8.43e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—obesity	8.32e-07	8.41e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—PIK3CA—obesity	8.32e-07	8.4e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PIK3CB—obesity	8.3e-07	8.39e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MTOR—obesity	8.3e-07	8.39e-06	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—AKT1—obesity	8.3e-07	8.38e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—obesity	8.17e-07	8.25e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—STAT3—obesity	8.17e-07	8.25e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARG—obesity	8.15e-07	8.23e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—COMT—obesity	8.13e-07	8.21e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—STAT3—obesity	8.12e-07	8.21e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MMP9—obesity	8.06e-07	8.15e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—POMC—obesity	8.04e-07	8.12e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GNB3—obesity	8.02e-07	8.1e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARGC1A—obesity	8.02e-07	8.1e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—INS—obesity	8e-07	8.08e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—HMOX1—obesity	7.98e-07	8.06e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MMP9—obesity	7.93e-07	8.01e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MMP9—obesity	7.92e-07	8e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—STAT3—obesity	7.9e-07	7.98e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MYC—obesity	7.86e-07	7.94e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MAPK8—obesity	7.84e-07	7.92e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—obesity	7.84e-07	7.92e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—AKT1—obesity	7.82e-07	7.9e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GNAS—obesity	7.81e-07	7.89e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—STAT3—obesity	7.78e-07	7.86e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MMP9—obesity	7.77e-07	7.85e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MAPK8—obesity	7.72e-07	7.79e-06	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—AKT1—obesity	7.71e-07	7.79e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MAPK8—obesity	7.7e-07	7.78e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—AKT1—obesity	7.7e-07	7.77e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—AKT1—obesity	7.68e-07	7.76e-06	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—obesity	7.65e-07	7.72e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOB—obesity	7.64e-07	7.72e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—obesity	7.59e-07	7.67e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MYC—obesity	7.59e-07	7.66e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—obesity	7.57e-07	7.65e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MAPK8—obesity	7.56e-07	7.63e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MYC—obesity	7.55e-07	7.62e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—AKT1—obesity	7.53e-07	7.61e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—obesity	7.53e-07	7.61e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—PIK3CA—obesity	7.49e-07	7.57e-06	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—obesity	7.49e-07	7.56e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PIK3CA—obesity	7.45e-07	7.53e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3CD—obesity	7.42e-07	7.5e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—PIK3CA—obesity	7.39e-07	7.47e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—obesity	7.37e-07	7.44e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MYC—obesity	7.34e-07	7.42e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—obesity	7.33e-07	7.4e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—obesity	7.32e-07	7.4e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—LPL—obesity	7.3e-07	7.37e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MYC—obesity	7.23e-07	7.3e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MMP9—obesity	7.22e-07	7.29e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—obesity	7.21e-07	7.28e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—STAT3—obesity	7.17e-07	7.24e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—GPX1—obesity	7.12e-07	7.19e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—STAT3—obesity	7.05e-07	7.13e-06	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AKT1—obesity	7.05e-07	7.13e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—STAT3—obesity	7.04e-07	7.11e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MAPK8—obesity	7.02e-07	7.09e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3R1—obesity	7.01e-07	7.08e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—NOS3—obesity	7.01e-07	7.08e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—AKT1—obesity	7e-07	7.07e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CD36—obesity	6.94e-07	7.01e-06	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AKT1—obesity	6.91e-07	6.98e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—STAT3—obesity	6.91e-07	6.98e-06	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKT1—obesity	6.8e-07	6.87e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PIK3CA—obesity	6.67e-07	6.74e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MYC—obesity	6.66e-07	6.73e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—obesity	6.65e-07	6.71e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—obesity	6.63e-07	6.7e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MTHFR—obesity	6.57e-07	6.64e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MYC—obesity	6.56e-07	6.62e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—obesity	6.54e-07	6.61e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MYC—obesity	6.54e-07	6.61e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—obesity	6.54e-07	6.61e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—obesity	6.53e-07	6.59e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3CB—obesity	6.47e-07	6.54e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARA—obesity	6.45e-07	6.51e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PIK3CA—obesity	6.44e-07	6.51e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MYC—obesity	6.42e-07	6.48e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—STAT3—obesity	6.42e-07	6.48e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—obesity	6.41e-07	6.48e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PIK3CA—obesity	6.41e-07	6.47e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—obesity	6.4e-07	6.47e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AGT—obesity	6.24e-07	6.31e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PIK3CA—obesity	6.23e-07	6.3e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PIK3CA—obesity	6.13e-07	6.2e-06	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKT1—obesity	6.12e-07	6.18e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOE—obesity	6.12e-07	6.18e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AKT1—obesity	6.09e-07	6.15e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CAV1—obesity	6.06e-07	6.12e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PIK3CA—obesity	6.05e-07	6.12e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOA1—obesity	6.05e-07	6.11e-06	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKT1—obesity	6.04e-07	6.1e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MYC—obesity	5.96e-07	6.02e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—obesity	5.95e-07	6.01e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—obesity	5.91e-07	5.97e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—obesity	5.7e-07	5.76e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—obesity	5.67e-07	5.73e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PIK3CA—obesity	5.66e-07	5.71e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PIK3CA—obesity	5.56e-07	5.62e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PIK3CA—obesity	5.55e-07	5.61e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PIK3CA—obesity	5.55e-07	5.6e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CG—obesity	5.52e-07	5.58e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—obesity	5.52e-07	5.57e-06	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKT1—obesity	5.45e-07	5.51e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PIK3CA—obesity	5.45e-07	5.5e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—obesity	5.43e-07	5.49e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARG—obesity	5.33e-07	5.38e-06	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKT1—obesity	5.26e-07	5.32e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—POMC—obesity	5.26e-07	5.31e-06	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKT1—obesity	5.23e-07	5.29e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—INS—obesity	5.23e-07	5.28e-06	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKT1—obesity	5.09e-07	5.14e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PIK3CA—obesity	5.06e-07	5.11e-06	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKT1—obesity	5.01e-07	5.06e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—obesity	5.01e-07	5.06e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AKT1—obesity	4.95e-07	5e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—obesity	4.93e-07	4.98e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—obesity	4.92e-07	4.97e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CD—obesity	4.85e-07	4.9e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—obesity	4.82e-07	4.87e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—obesity	4.79e-07	4.84e-06	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKT1—obesity	4.62e-07	4.67e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3R1—obesity	4.58e-07	4.63e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NOS3—obesity	4.58e-07	4.63e-06	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKT1—obesity	4.55e-07	4.59e-06	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKT1—obesity	4.54e-07	4.58e-06	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AKT1—obesity	4.53e-07	4.58e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—obesity	4.48e-07	4.53e-06	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKT1—obesity	4.45e-07	4.5e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CB—obesity	4.23e-07	4.27e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—obesity	4.19e-07	4.23e-06	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKT1—obesity	4.14e-07	4.18e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PIK3CA—obesity	3.95e-07	3.99e-06	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AKT1—obesity	3.22e-07	3.26e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PIK3CA—obesity	2.58e-07	2.61e-06	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AKT1—obesity	2.11e-07	2.13e-06	CbGpPWpGaD
